Amazon cover image
Image from Amazon.com

HIV-1 integrase : mechanism and inhibitor design / [edited] by Nouri Neamati.

Contributor(s): Material type: TextTextSeries: Wiley series in drug discovery and developmentPublication details: Hoboken, N.J. : Wiley, ©2011.Description: 1 online resource (xiii, 506 pages, [16] pages of plates) : illustrations (some color)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781118015377
  • 1118015371
  • 9781118015353
  • 1118015355
Subject(s): Genre/Form: Additional physical formats: Print version:: HIV-1 integrase.DDC classification:
  • 616.97/9201 22
LOC classification:
  • QR201.A37 H547 2011eb
NLM classification:
  • QV 268.5
Online resources: Summary: This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Print version record.

Includes bibliographical references and index.

This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1.